The scheme of the suggested therapy is: (i) the expression of a vector encoding genetically modified DNase I that escapes inactivation by G-actin; (ii) an increase in the amount of DNase I in tumor cells; (iii) the introduction of double-stranded breaks in intracellular DNA, and the triggering of apoptosis. This evidence concerns the gene DNASE1 and neoplasm.